659 results on '"Edwards, I. Ralph"'
Search Results
2. Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts
3. Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®
4. Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?
5. Pharmacovigilance is … Vigilance
6. The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance
7. Comment on “Safety of Human Papillomavirus Vaccines: An Updated Review”
8. Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum
9. Adverse Drug Effects and Their Clinical Management: A Personal View
10. Pharmacovigilance for Children’s Sake
11. Antipsychotic Drugs And Heart Muscle Disorder In International Pharmacovigilance: Data Mining Study
12. Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium Guidance
13. The Development and Evaluation of Triage Algorithms for Early Discovery of Adverse Drug Interactions
14. Communicating the New Pharmacovigilance Landscape
15. Decision Dilemmas: Worse in Emerging Economies
16. Good Pharmacovigilance Practice and the Curate’s Egg
17. Clinical Diagnosis: A Topic Worth Revisiting for Pharmacovigilance
18. Prevention and Pharmacovigilance: What Should We Do, What Can We Do?
19. Adverse Drug Reactions: Finding the Needle in the Haystack: Pharmacovigilance Is Improving: Now We Need to Ensure That Patients Benefit
20. Methylprednisolone-induced hepatotoxicity: experiences from global adverse drug reaction surveillance
21. Fraudulent and Substandard Medicines: Getting Away with Murder?
22. Suspected Adverse Drug Reactions Reported For Children Worldwide: An Exploratory Study Using VigiBase
23. Social Media and Networks in Pharmacovigilance: Boon or Bane?
24. Dose Variations Associated with Formulations of NSAID Prescriptions for Children: A Descriptive Analysis of Electronic Health Records in the UK
25. Reporting Patterns Indicative of Adverse Drug Interactions: A Systematic Evaluation in VigiBase
26. Pharmacovigilance and the Null Hypothesis: Do We do Much for Public Health?
27. African Heat
28. Reflections on Attribution and Decisions in Pharmacovigilance
29. Temporal pattern discovery in longitudinal electronic patient records
30. First, Catch Your Signal!
31. Wonder Vigilance
32. Tomorrow’s World
33. Clinical stories are necessary for drug safety
34. A Risk Worth Taking?
35. Understanding and Communicating Key Concepts in Risk Management: What do we Mean by Benefit and Risk?
36. The ISoP Bengt-Erik Wiholm Memorial Lecture
37. Impact of Stratification on Adverse Drug Reaction Surveillance
38. The future of pharmacovigilance: a personal view
39. Statins, Neuromuscular Degenerative Disease and an Amyotrophic Lateral Sclerosis-Like Syndrome: An Analysis of Individual Case Safety Reports from Vigibase
40. Duplicate detection in adverse drug reaction surveillance
41. What is Drug Safety?: Celebrating 20 Years of the Drug Safety Journal
42. What are the Real Lessons from Vioxx®?
43. The WHO World Alliance for Patient Safety: A New Challenge or an Old One Neglected?
44. Assessing the Impact of Drug Safety Signals from the WHO Database Presented in ‘SIGNAL’: Results from a Questionnaire of National Pharmacovigilance Centres
45. Challenges of safe medication practice in paediatric care – a nursing perspective
46. Labelling and ‘Dear Doctor’ Letters: Are They Noncommittal?
47. Signal Selection and Follow-Up in Pharmacovigilance
48. A Data Mining Approach for Signal Detection and Analysis
49. A Retrospective Evaluation of a Data Mining Approach to Aid Finding New Adverse Drug Reaction Signals in the WHO International Database
50. The Value of Reporting Therapeutic Ineffectiveness as an Adverse Drug Reaction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.